| an assessment of onrab oral rabies vaccine persistence in free-ranging mammal populations in ontario, canada. | onrab is a rabies glycoprotein recombinant human adenovirus type 5 oral vaccine developed for application in baits to control rabies in wildlife populations. prior to widespread use of onrab, both the safety and effectiveness of this vaccine required investigation. while previous research has focused on field performance and the persistence and pathogenicity of onrab in captive animals, we sought to examine persistence and shedding of onrab in populations of free-ranging target and non-target ma ... | 2013 | 23499602 |